Subscribe


PD breaking news – Symbion to be taken over by EBOS

EBOS confirms Symbion acquisition.

Symbion Pharmacy Services is set to be acquired by NZ-based EBOS Group, in a NZ$1.1 billion transaction which “will create the largest and most diversified Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products.”

As foreshadowed in Pharmacy Daily this morning, existing Symbion management will remain in place, with ceo Patrick Davies saying the structure of the new entity further strengthens Symbion’s commitment to the Australian pharmacy industry.

“While this agreement creates an organisation that has very significant scale, resources and opportunities, it achieves this while maintaining everything that is important to our customers,” he said.

EBOS will acquire 100% of Symbion, while the Zuellig Group, which currently owns Symbion, will take a 40% shareholding of the enlarged EBOS Group.

The Symbion brand will remain in place, along with “the stable influence of the Zuellig Group as a major shareholder,” Davies said, adding that “the values and philosophies of Symbion and EBOS are very strongly aligned”.

EBOS ceo Mark Waller said the deal would be transformational for EBOS.

“This is a rare opportunity to create a clear trans-Tasman market leader,” he said.

A Special General Meeting of EBOS will take place in Christchurch on 14 June, and if all required conditions are satisfied including approval by shareholders the transaction is expected to complete in early July.

More information in Pharmacy Daily as it comes to hand.


The above Breaking News Alert was sent to Pharmacy Daily subscribers on 29 May 13

Make a comment...



Established in 2007, Pharmacy Daily is Australia's leading pharmacy industry publication, and is sent as a free subscription to people across the industry as a PDF newsletter every weekday.

Register for Pharmacy Daily trial subscription

To sign up for a free subscription, click on the button at right.

Click here to see a sample issue of Pharmacy Daily.

Click here for more information on subscriptions.

Alternatively, you can search our site via the search box on the right hand side of the page, or find other content below.

Recent Pharmacy Daily articles

19 Jan

Dispensary Corner 19 Jan 18 - IT MAKES perfect sense for the operation ...


19 Jan

PBA data released - THE Pharmacy Board of Australia has released ...


19 Jan

‘Out of pocket pain’ - THE Consumers Health Forum (CHF) has announced ...


19 Jan

Cannabis PBS listing? - VICTORIAN Health Minister Jill Hennessy has confirmed ...


19 Jan

Industrial hemp meet - THE Australian Industrial Hemp Conference is calling ...


19 Jan

S3 advertising permitted - THE Therapeutic Goods Administration has confirmed that ...


19 Jan

Codeine story ‘misleading’ - WHILE the rescheduling of products containing codeine ...


18 Jan

Travel Specials 18 Jan 18 - VIEW & Verandah Sale by Holland America ...


18 Jan

Dispensary Corner 18 Jan 18 - NEWLYWEDS from Northern Ireland have wasted no ...


18 Jan

CW float speculation - THE owners of Chemist Warehouse may be ...


18 Jan

Life-Long Learning - THE Australian Pharmacy Council has announced the ...


18 Jan

FIP Glasgow regos - REGISTRATIONS have opened for the 78th International ...


18 Jan

Vic Guild election - THE Victorian Branch of the Pharmacy Guild ...


18 Jan

Blood clot warning - A DRUG that women use as a ...


18 Jan

TGA reformats PIs - EFFECTIVE 01 Jan this year, all product ...


18 Jan

PBA competency standards - THE Pharmacy Practitioner Development Committee (PPDC) met ...


18 Jan

The eyes have it - RESEARCH conducted by the University of Queensland ...


18 Jan

Pharmacy role in National Pain Plan - PHARMACISTS have been identified as key advisors ...


18 Jan

SHPA affirms codeine move - THE Society of Hospital Pharmacists of Australia ...


17 Jan

Ibuprofen Double Strength 400 - ARROW Pharmaceuticals announces the launch of Chemists' ...



Show Pharmacy Daily items by month: